DC-SIGN, a Dendritic Cell–Specific
DC-SIGN真核表达载体的构建及其稳定转染HeLa细胞系的建立
DC-SIGN真核表达载体的构建及其稳定转染HeLa细胞系的建立王欣;詹媛;王琰;周恩民;丁铲;谭磊;陆凤;徐乐乐;仇旭升;宋翠萍;孙英杰;廖瑛;茅翔【摘要】为研究新城疫病毒(Newcastle disease virus, NDV)与树突状细胞特异性粘附分子-3-结合非整合素分子(dendritic cell specifi c intercellular adhesion molecule-3-grabbing non-integrin,DC-SIGN)的相互作用对NDV感染树突状细胞(dendritic cell,DC)的影响,本研究拟构建能够稳定表达DC-SIGN蛋白的细胞系,为研究DC-SIGN蛋白与病毒蛋白互作提供基础.以小鼠DCs提取的cDNA为模板,通过PCR方法获得DC-SIGN基因,连入真核表达载体,并命名为pcDNA-DC-SIGN,利用LipofectamineTM2000转染HeLa细胞,G418进行药物压力筛选,经RT-PCR和Western blot鉴定,获得了一株可以高效表达DC-SIGN蛋白的HeLa 细胞,且经过多次传代后仍然可以稳定表达DC-SIGN,说明该细胞系构建成功.%To investigate the infl uence of the interaction between Newcastle diseases virus (NDV) protein with dendritic cells specifi c adhesion molecules - 3 - grabbing non-integrin (DC-SIGN) on NDV infection of dendritic cell (DC), we generated a Hela cell line stably expressing DC - SIGN protein for studying DC - SIGN protein and virus protein interactions. The cDNA was extracted from mouse DCs and used as template. The DC - SIGN gene was amplifi ed in polymerase chain reaction (PCR) for construction of eukaryotic expression vector pcDNA-DC-SIGN, which was then transfected into HeLa cells using LipofectamineTM 2000. A HeLa cell line effi ciently expressing DC - SIGN protein was identifi ed through RT-PCR and Western blot, and the specifi c Hela cell line was stable after many passages.【期刊名称】《中国动物传染病学报》【年(卷),期】2015(023)003【总页数】5页(P12-16)【关键词】树突状细胞特异性粘附分子-3-结合非整合素分子;新城疫病毒;树突状细胞;HeLa细胞【作者】王欣;詹媛;王琰;周恩民;丁铲;谭磊;陆凤;徐乐乐;仇旭升;宋翠萍;孙英杰;廖瑛;茅翔【作者单位】西北农林科技大学动物医学院,杨凌 712100;中国农业科学院上海兽医研究所,上海 200241;中国农业科学院上海兽医研究所,上海 200241;中国农业科学院上海兽医研究所,上海 200241;西北农林科技大学动物医学院,杨凌 712100;中国农业科学院上海兽医研究所,上海 200241;中国农业科学院上海兽医研究所,上海200241;中国农业科学院上海兽医研究所,上海 200241;西北农林科技大学动物医学院,杨凌 712100;中国农业科学院上海兽医研究所,上海 200241;中国农业科学院上海兽医研究所,上海 200241;中国农业科学院上海兽医研究所,上海 200241;中国农业科学院上海兽医研究所,上海 200241;中国农业科学院上海兽医研究所,上海200241【正文语种】中文【中图分类】S852.659.5树突状细胞特异性粘附分子-3-结合非整合素分子(dendritic cell specific intercellular adhesion molecule-3 grabbing non integrin,DC-SIGN),又称CD209,由美国科学家在研究人类免疫缺陷病毒(Humanimmunodeficiency virus,HIV)感染机制过程中发现。
筛选抑制DC - SIGN蛋白质的DNA适配子 翻译
筛选抑制DC - SIGN蛋白质的DNA适配子收到:2007年4月16日/接受:2007年7月12日/网上出版:2007年7月28日©斯普林格科学业务媒体有限责任公司2007/摘要树突状细胞(DCs)是专门的抗原提呈细胞,因其是免疫反应的控制器而逐渐受到重视,特别是T细胞反应。
除了把抗原提呈给T细胞,在免疫调节方面树突状细胞能完成许多其他功能。
树突状细胞特定细胞间的粘附分子(ICAM)-3占据非整合素位点(DC - SIGN),非整合素是一种新型的受体,在树突状细胞迁移和黏附、炎症反应、T细胞活化、启动免疫反应、病原体和肿瘤的免疫逃逸中起重要作用。
DC-SIGN介导的树突状细胞在T细胞表面结合细胞间粘附分子3,在血管内皮细胞(EC)内结合细胞间黏附分子2,并参与树突状细胞和T细胞以及血管内皮细胞间的初步反应。
指数富集配体系统进化方法的过程是从随机序列中挑选出能特异性结合目标分子的单链寡聚核苷酸。
在这项研究中,我们采用SELEX法选择不是DC –SIGN蛋白的DNA适配子,并测定他们对DC –SIGN的亲和力。
最终,获得DC –SIGN高亲和力的合适的适体,它作为有效地抗DC –SIGN的单克隆抗体,阻止树突状细胞粘附到血管内皮细胞上。
关键词树突状细胞树突状细胞特定细胞间的粘附分子(ICAM)-3 占据非整合素位点适配子SELEX简介适配子的寡核苷酸(DNA或RNA),可结合具有高亲和力和特异性的广泛靶分子,如药物,蛋白质,以及其他有机或无机分子[1-5]。
它们是由体外筛选过程中产生的,即1990年首次报道的指数富集配体系统进化(SELEX实验)[6,7]。
SELEX方法已允许从大量的低聚物的随机序列(DNA或RNA库)中鉴定独特的RNA / DNA分子,他们可结合具有高亲和力和特异性靶分子。
适配子显示出对他们的目标非常高的亲和力,解离常数由通常的微摩尔到低皮摩尔范围,相比之下,有时甚至比一些单克隆抗体更好[8]。
DC-SIGN在炎症性肠病肠黏膜上皮细胞表达及与肠黏膜损伤的关系
DC-SIGN在炎症性肠病肠黏膜上皮细胞表达及与肠黏膜损伤的关系曾敬清;林凯;苏林;杨芬;王歆琼;刘伟;吴菁;周同;许春娣【摘要】目的探讨树突状细胞(DC)表型分子DC-SIGN在炎症性肠病(IBD)肠黏膜上皮细胞的表达及临床意义.方法选取2006年1月至2010年6月收治的IBD患儿32例,其中克罗恩病18例,溃疡性结肠炎14例;10例正常对照儿童.免疫组织化学方法检测肠黏膜组织DC-SIGN表达;人肠上皮细胞株NCM460经LPS (50 ng/ml)刺激,Western-Blot印迹、流式细胞术分别检测肠上皮细胞DC-SIGN以及共刺激分子CD80、CD86表达,分析肠黏膜上皮细胞DC-SIGN表达与IBD及其肠黏膜损伤的关系.结果 DC-SIGN在正常对照儿童肠黏膜组织中基本不表达或低表达,而IBD患儿肠黏膜组织中表达增强,并以肠黏膜上皮细胞为主,其中克罗恩病为61.11% (11/18),溃疡性结肠炎为50.00% (7/14),与正常对照儿童比较,差异均有统计学意义(P<0.05); DC-SIGN表达与IBD患儿的疾病活动度呈正相关(r=0.475,P<0.01).体外培养肠上皮细胞经LPS刺激后DC-SIGN表达增强,且CD80、CD86表达相应上调.结论 IBD患儿肠上皮细胞表达DC-SIGN,与细胞转分化有关;DC-SIGN可能介导肠上皮细胞在IBD及肠黏膜损伤中发挥DC样的免疫调节作用.%Objective To explore the expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) on intestinal epithelial cell (IEC) in inflammation bowel disease and its possible clinical significance in the intestinal mucosal lesion. Methods A total of 32 children diagnosed with inflammation bowel disease (18 cases of Crohn's disease and 14 cases of ulcerative colitis) and 10 healthy children (control) were recruited from Jan. 2006 to Jun. 2010. The expressions of DC-SIGN,CD80 and CD86 on IECS (NCM460) with or without LPS (50ng/ml) stimulation was detected by western-blot and flow cytometry. The relationship between the expression of DC-SIGN and the mucosal lesion was analyze. Results The higher expression of DC-SIGN was observed in intestinal biopsies from the patients with inflammation bowel disease, as compared with the normal (P<0.05). The positive rate of DC-SIGN expression, mainly occurred on IECs, is 61.11% (11/18) in crohn's disease and is 50% (7/14) in ulcerative colitis. Meanwhile the expression of DC-SIGN was positively correlated with disease activity index (r=0.475, P<0.01). The expressions of DC-SIGN on NCM460 cells were up-regulated by LPS stimulation in vitro, and meanwhile CD80, CD86 expression was up-regulated accordingly. Conclusions This study demonstrated that the intestinal epithelial cells of children with BD were capable of expressing DC-SIGN, which may be related to cell transdifferentiation. DC-SIGN probably has an important immunomodulatory effect on the injury of intestinal mucous membrane mediated by IECs in the inflammation bowel disease.【期刊名称】《临床儿科杂志》【年(卷),期】2013(031)001【总页数】5页(P5-9)【关键词】炎症性肠病;DC-SIGN;免疫调节;儿童【作者】曾敬清;林凯;苏林;杨芬;王歆琼;刘伟;吴菁;周同;许春娣【作者单位】上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025;上海交通大学医学院附属瑞金医院儿科,上海200025【正文语种】中文【中图分类】R725炎症性肠病 (inflammatory bowel disease,IBD) 发病机制仍不甚清楚,可能与遗传、环境、感染及免疫等因素有关[1,2]。
DC—SIGN与肿瘤关系的研究进展
DC—SIGN与肿瘤关系的研究进展摘要:树突状细胞特异性细胞间黏附分子-3结合非整合素因子(dendritic cell specific intercellular-adhesion-molecule-3 grabbing non-integrin,DC-SIGN)是一种主要表达于树突状细胞(dendritic cell,DC)表面的特异性受体,属于C型凝集素超分子家族。
DC-SIGN不仅能与细胞间黏附分子-2(intercellular adhesion molecule-2 ,1-CAM-2)和细胞间黏附分子-3 (intercellular adhesion molecule-3,ICAM-3)等结合,还能识别HIV、登革病毒、巨细胞病毒等病原微生物,从而参与了这些病原体的感染过程,与多种感染性疾病的发病机制密切相关。
近年来,有学者发现DC-SIGN还与肿瘤的发生、免疫、易感性有关,也因此受到了更广泛的关注。
对DC-SIGN与肿瘤之间的关系进行更深一步的研究将有助于了解相关肿瘤疾病的发生机制,为促进其诊疗进展奠定基础。
关键词:树突状细胞特异性细胞间黏附分子-3结合非整合素因子(DC-SIGN);肿瘤;研究进展属于专职抗原提呈细胞的树突状细胞(den-dritic cells,DCs)是一种异构的骨髓来源细胞,其通过表达模式识别受体(pattern-recognition re-ceptors,PRR)区分并特异地识别病原相关分子模式,从而参与到机体的固有免疫反应和适应性免疫反应中[1]。
DCs表达的PRR主要有Toll样受体(TLR)、NOD样受体(NLR)和C型凝集素受体(CLR),其中具有Ca2+依赖性的CLR是一种能识别多聚糖抗原的模式识别受体[2J。
树突状细胞特异性细胞间黏附分子一3结合非整合素因子(DCspecific intercellular -adhesion -molecule -3 grab-bing non-integrin,DC -SIGN,也称CD209)就是DCs上特异的C型凝集素受体[3]。
人DC-SIGN蛋白克隆及免疫学功能初探的开题报告
人DC-SIGN蛋白克隆及免疫学功能初探的开题报告一、研究背景DC-SIGN(dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin)是一种转膜型C型凝集素家族成员,广泛分布于树突状细胞(DC)、巨噬细胞和内皮细胞等多种免疫细胞表面,主要参与细胞间黏附、炎症反应和抗菌作用等生理过程。
DC-SIGN可以识别和结合多种病原体的糖基化表面分子,如HIV、结核分枝杆菌、流感病毒等,因此在免疫学上具有重要意义。
目前,已有许多研究对DC-SIGN的结构、生物学功能及组织学表达进行深入探究,但对其免疫学功能机制的认识仍然有待进一步探索。
因此,本研究旨在构建人源DC-SIGN蛋白的表达载体,并利用该载体在细胞水平上探索DC-SIGN在细菌感染、炎症反应等免疫学过程中的作用机制。
二、研究内容1. 构建DC-SIGN表达载体本研究将以人源DC-SIGN基因为模板,设计合适的引物并利用PCR技术扩增该基因的全长序列。
随后,将所得PCR产物克隆入pET-28a表达载体,构建出含有His 标签的DC-SIGN表达载体。
2. 表达、纯化及鉴定DC-SIGN蛋白将构建好的DC-SIGN表达载体转化到大肠杆菌(E. coli)BL21(DE3)菌株中,利用IPTG诱导表达。
用超声破碎法裂解大肠杆菌,利用His-Trap柱层析纯化目的蛋白,通过Western blot和质谱等技术手段鉴定所得蛋白的表达情况和纯度,确保获得纯净的人DC-SIGN蛋白。
3. 免疫学功能初探利用获得的DC-SIGN蛋白,研究其在细菌感染、炎症反应等免疫学过程中的作用机制。
例如,利用荧光染色技术观察DC-SIGN在静脉炎症模型大鼠中的表达情况,通过ELISA法检测DC-SIGN与大肠杆菌等细菌的结合能力以及其对炎症因子的调控作用等。
三、研究意义本研究拟通过构建DC-SIGN表达载体、表达、纯化及鉴定DC-SIGN蛋白,并初步探讨其在免疫学中的作用机制,为深入研究DC-SIGN蛋白的免疫学功能提供基础数据和实验依据。
免疫细胞在急性肾损伤中的作用研究进展
免疫细胞在急性肾损伤中的作用研究进展廖进;于泓【摘要】免疫反应与急性肾损伤的发生发展息息相关,虽然作用机制未完全明确,但初步的研究发现,多种免疫细胞参与了急性肾损伤相关免疫炎症反应,包括中性粒细胞、树突状细胞(DC)、巨噬细胞、自然杀伤细胞(NK)、T淋巴细胞、调节性T细胞及NKT细胞等,DC、T淋巴细胞、调节性T细胞在其中起的作用最为重要。
DC既是抗原提呈细胞(APC),也是重要的免疫细胞,未成熟DC进入肾组织后可通过分泌细胞损伤因子直接损伤肾脏,而成熟DC可通过表达共刺激分子等,激活T细胞反应而损伤肾脏;T淋巴细胞表面的共刺激分子与APC表面的配体结合,可加重或减轻急性肾损伤;调节性T细胞是具有免疫抑制功能的细胞,通过抑制T细胞的活化、增殖而对急性肾损伤起保护作用。
【期刊名称】《山东医药》【年(卷),期】2016(056)047【总页数】3页(P104-106)【关键词】免疫细胞;急性肾损伤;树突状细胞;T细胞;调节性T细胞【作者】廖进;于泓【作者单位】遵义医学院附属医院,贵州遵义563000;遵义医学院附属医院,贵州遵义563000【正文语种】中文【中图分类】R692.5免疫反应(包括天然免疫反应和获得性免疫反应)在急性肾损伤(AKI)的发病机制中发挥了重要作用。
AKI发生后多种免疫细胞被激活,包括中性粒细胞、树突状细胞(DC)、巨噬细胞、自然杀伤细胞(NK)、T淋巴细胞、调节性T细胞及NKT细胞等。
近年来研究发现,DC、T淋巴细胞、调节性T细胞在其中起重要作用。
现将免疫细胞在急性肾损伤中的作用综述如下。
DC是一组具有特异形态、结构和功能的抗原提呈细胞,同时也是重要的免疫细胞,按来源可以分为髓样DC和淋巴样DC,肾脏DC(KDC)属于髓样DC(MDC),由骨髓中的巨噬细胞和DC前体细胞分化而来,主要分布于肾小管间质,既参与肾内炎症反应,又与肾脏损伤修复有关。
细菌感染(特别是革兰阴性菌)和缺血缺氧均是AKI发生的重要危险因素。
解释了 HIV 入侵宿主细胞的一些途径
HIV vaccines and microbicides hold promise for prevent‑ing the acquisition of HIV‑1 and HIV‑2, the two viruses that cause AIDS, but the success of designing such agents needs a clear understanding of where HIV first encoun‑ters its target cells — primarily T cells, macrophages and dendritic cells (DCs) — and how it gains entry at various sites to eventually establish infection. HIV infection has rapidly spread since the early 1980s to become an epi‑demic disease (see the UNAIDS/WHO AIDS epidemic update) that is largely maintained by sexual transmis‑sion through the lower genital and rectal mucosa (FIG. 1, TABLE 1). Here, we have endeavoured to assemble the current knowledge on the acquisition of HIV at mucosal sites, confining our discussion to the lower genital mucosa. We clearly recognize that other sites of entry, such as the blood, placenta and gastrointestinal mucosa (BOX 1), are also important for HIV acquisition but these are beyond the scope of this Review.Many studies have provided insights into certain aspects of HIV and simian immunodeficiency virus (SIV) mucosal entry by carrying out detailed examinations of the relevant tissues and target cells following their in vivo, ex vivo or in vitro exposure to the virus. This Review discusses experimental systems that use the same mucosal source to avoid confusion and the inconsistencies that often emerge when findings from one system are extrapolated to those of another. Where appropriate, we have emphasized the benefits and limitations of the experimental approaches, important considerations in the interpretation of findings and their relevance for future studies.HIV invasion in the female genital tract Anatomical sites. An estimated 30–40% of all new HIV‑1 infections in women occur through vaginal intercourse, which carries a lower HIV transmission probability per exposure event than anal intercourse or parenteral inoculation (TABLE 1). Although HIV‑1 can infect the vaginal, ectocervical and endocervical mucosa (FIG. 1), the relative contribution of each site to the establish‑ment of the initial infection is not known. The multi‑layered squamous epithelium that covers the vagina and ectocervix, when intact, provides better mechani‑cal protection against HIV invasion than the single‑layer columnar epithelium that lines the endocervix. However, the greater surface area of the vaginal wall and ectocervix, which often exceeds 15 times that of the endocervix, provides more potential access sites for HIV entry, particularly when breaches occur in the epithelial‑cell layer. HIV or SIV can establish an initial infection solely through invasion of the vaginal mucosa, as shown in women who lack a uterus at birth1 and in female macaques after surgical removal of the uterus2. In fact, selective transmission of HIV through the vaginal mucosa rather than the cervix may commonly occur, as suggested by a recent large, randomized, controlled, prevention clinical trial in African women. In this study, no significant reduction in HIV‑1 acquisition occurred in women using a diaphragm compared with the con‑trol group3. However, the observed potential benefit of blocking HIV‑1 exposure to the cervix may have been undermined because the sexual partners of the women in the group using a diaphragm reported lower condom use than those in the control group.The region where the ectocervix transforms into the endocervix (FIG. 1) can have enriched CD4+ T‑cell populations and therefore may be a particularly sus‑ceptible site for HIV entry. Whether HIV can cross the endocervical mucus plug, reach the uterine cavity and*Vaccine and Infectious Disease Institute,Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. Departments of ‡Medicine, §Obstetrics and Gynecology, ||Global Health and Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington 98195, USA. Correspondence to M.J.M., e‑mail: jmcelrat@ doi:10.1038/nri2302 Published online 12 May 2008Setting the stage: host invasion by HIV Florian Hladik*‡§ and M. Juliana McElrath*‡||Abstract | For more than two decades, HIV has infected millions of people worldwide each year through mucosal transmission. Our knowledge of how HIV secures a foothold at both the molecular and cellular levels has been expanded by recent investigations that have applied new technologies and used improved techniques to isolate ex vivo human tissue and generate in vitro cellular models, as well as more relevant in vivo animal challenge systems. Here, we review the current concepts of the immediate events that follow viral exposure at genital mucosal sites where most documented transmissions occur. Furthermore, we discuss the gaps in our knowledge that are relevant to future studies, which will shape strategies for effective HIV prevention.NATURe ReVIeWS |immunology ADVANCe ONlINe pUblICATION | |©2008Nature Publishing GroupNature Reviews | Immunologyab Simian–HIV (SHIV). SHIVs are chimericviruses that are created byinserting the envelope protein(Env), the transcriptionaltransactivator (T at) and the regulator of virion geneexpression (Rev) of HIV into theSIV MAC239 clone. Depending onthe particular HIV Env protein,these SHIVs have different in vivo characteristics. The SHIV chimeric viruses are bestused for testing antibodiesspecific for HIV in non-humanprimate models. invade through the mucosa of the upper genital tract has not been well examined. In principle, uterine tissue is susceptible to infection if directly inoculated with HIV 4. Uterine simian–HIV (SHIV) infection has been shown in one monkey following vaginal inoculation two days earlier, an interval that is probably too short for stromal or lymphatic spread from the lower genital tract 5. This indicated that ascent of the virus through the endocervical mucus plug may be possible, but this observation has not been confirmed in humans. Conceivably, the upper mucosal tract may become more vulnerable to HIV‑1 penetration during ovula‑tion, a period when rising oestrogen levels alter the endocervical mucus making its consistency less viscous and more alkaline.both(FIG. 2)6–10. This has been shown in vivo in female macaques 11 and in mice 12, and13. studies using human cervical explants have also (REFS 14,15). Initially, cervical mucus can trap16,17. Conceivably, HIV virions that are initially free, or those that are transcytosis , endocytosis and(FIG. 2). The understanding of these events has been 18–20. Transcytosis tissue. On release from the epithelial cells, the virions readily infect susceptible leukocytes 21,22. Interestingly,cell‑associated virions secreted from infected seminal leukocytes appear markedly more efficient at transcy‑tosis than cell‑free virions 7,10,21. It has been reported that virions can also productively infect the cervical epithelial cells themselves 6, although this remains controversial 18,23. Conceivably, HIV‑1 can also be transported through the cervicovaginal epithelium to the draining lymphatics by donor lymphocytes and macrophages, as has been suggested in mouse studies 6,24. Our ex vivo experiments using sheets of isolated vagi‑nal epithelium, devoid of mucosal stroma, confirmed that HIV‑1 virions are sequestered in endocytic com‑partments and in the cytosol of epithelial cells (FIG. 3).Interestingly, although the experimental conditions permitted HIV‑1 access to both the luminal and basalsides of the epithelium, the virions were detected exclu‑sively in the basal and suprabasal epithelial cells (F.H., p . Sakchalathorn and M.J.M., unpublished observations). This suggests that initially, rather than entering and traversing superficial epithelial cells in the vagina and ectocervix, HIV‑1 probably disperses through the nar‑row gaps between them 16, as depicted in FIG. 2. This route might then permit HIV‑1 to directly contact and infect intraepithelial Langerhans cells (lCs) and CD4+ T cells 25 (see later), or it might allow HIV‑1 to reach suprabasal or basal epithelial cells that are more susceptible to viral sequestration and transcytosis. Importantly, components of human semen, most notably amyloid fibrils that form the single-layer columnar epithelium of the endocervix. The endocervical canal is filledwith mucus, providing a barrier against the ascent of pathogens. However, ovulation isaccompanied by hydration and alkalinization of the mucus plug, possibly decreasing itsbarrier function. Infection in women can also ensue when HIV-1 invades the single-layer columnar epithelium of the rectum following receptive anal intercourse. b | Inmen, viral invasion occurs most frequently through the inner foreskin and the penileurethra as a consequence of penile–vaginal or penile–anal intercourse. Thinly stratified columnar epithelial cells line most of the urethra except for the fossa navicularis near the external meatus (exit hole), which is covered by non-keratinized squamous epithelium. The glans penis and the outer foreskin are protected by keratinized squamous epithelium, which provides a strong mechanical barrier against HIV invasion. By contrast, a thin and poorly keratinized squamous epithelium covers the innerforeskin, rendering this site vulnerable to HIV invasion. Men are also infected by viralinvasion through the rectum.| ADVANCe ONlINe pUblICATION/reviews/immunol© 2008Nature Publishing GroupT ranscytosisThe process of transport of material, including HIV virions, across a cell layer by uptake on one side of the cell into a coated vesicle. The vesicle might then be sorted through the trans -Golgi network and transported to the opposite side of the cell, where itscontents are released into the extracelluar space.Langerhans cell(LC). A type of dendritic cell that is localized in thesquamous epithelial layer of the skin and certain mucosae.SyndecansSingle transmembrane domain proteins that carry three to five heparan sulphate andchondroitin sulphate chains that allow for interaction with various ligands including residues on the HIV-1 gp120 protein.from naturally occurring fragments of seminal prostatic acidic phosphatase, can capture virions and promote their attachment to epithelial cells and leukocytes, thus increasing infectivity 26.Several proteins expressed on the surface of epithelial cells may mediate the attachment of HIV‑1. Two cell‑surface glycosphingolipids, sulphated lactosylceramide expressed by vaginal epithelial cells 27 and galactosyl‑ceramide expressed by ectocervical epithelial cells 18,28, bind HIV‑1 gp120 and foster transcytosis 21. Interactions of HIV‑1 gp120 with transmembrane heparan sulphate proteoglycans (syndecans ) expressed by genital epithe‑lial cells can also contribute to HIV‑1 attachment and entry 19,22. Recently, gp340, a splice variant of salivary agglutinin that is expressed by cervical and vaginal epithelial cells, was shown to specifically bind to the HIV envelope protein and to enhance the passage of HIV through the epithelium giving it access to suscep‑tible leukocytes 29. One research group found that the β1 subunit of integrins expressed by cervical epithelial cells from some explants, but not all, bound virions that were presumably coated with fibronectin, which is abundant in human semen 16. Detection of HIV‑1 chemokine co‑receptor expression has been inconsist‑ent: one study did not detect the expression of either CC‑chemokine receptor 5 (CCR5) or CXC‑chemokine receptor 4 (CXCR4) by cervical epithelial cells 18, another reported the expression of CXCR4 by these cells 20, whereas another reported the exclusive expression of CCR5 (REF . 28).Regardless of the mode, the penetration of virus through the cervicovaginal epithelium in vivo occurs rapidly within 30–60 minutes of exposure, as shown in SIV‑infected macaques 30. Once within the epithelium,Table 1 |Contribution of HIV invasion sites to global HIV infections* *Table adapted from the UNAIDS/WHO AIDS epidemic update and men. §Includes MSM, bisexual men and women infected via anal receptive intercourse. ||Mother-to-child transmission. ¶Mostly intravenous drug use, butincludes infections by transfusions and health-care-related accidents. GI, gastrointestinal.NATURe ReVIeWS | immunologyADVANCe ONlINe pUblICATION |© 2008Nature Publishing GroupActivated memory T cell Resting memory T cellLangerhans cellEpithelial cell Stromal dendritic cell Array(DCs), reach close to the luminal surface of the mucosa. Monocytic precursor cells differentiate on arrival either intomacrophages or DCs, and DCs may differentiate further into subsets. Three stromal DC subsets have been identified in humanskin, distinguished by blood DC antigen 1 (BDCA1), CD1 and CD14 expression patterns64, but their presence and susceptibilityto HIV have not been determined in the mucosa. Infected donor cells and free virions may migrate along the abrasion anddirectly contact various target cells in the mucosal epithelium and stroma. Resident mucosal leukocytes such as DCs andT cells tend to cluster in these regions, creating susceptible foci for infection. Characteristic phenotypic cell receptors andreceptors relevant for HIV binding and infection are shown on the top of the figure (A). The possible pathways of HIVpenetration are summarized in B. a | Free HIV virions or HIV-infected donor cells are trapped in mucus, resulting in penetrationof the free virions into gaps between epithelial cells or attachment of HIV-infected donor cells to the luminal surface of themucosa and secretion of virions on contact. The virions are then captured and internalized into endocytic compartments byLangerhans cells that reside within the epithelium. b | HIV can also fuse with the surface of intraepithelial CD4+ T cells, followedby productive infection of these cells. c | Infected donor cells or free virions can immigrate along physical abrasions of theepithelium into the mucosal stroma. There they are taken up by lymphatic or venous microvessels and transported to locallymph nodes or into the blood circulation, respectively, or they make contact with stromal DCs, T cells and macrophages.d | Virions can transcytose through epithelial cells near or within the basal layer of the squamous epithelium (see also Figure 3),productively infect basal epithelial cells, be internalized into endocytic compartments, or penetrate between epithelial cells.e | Once within the stroma, virions can productively infect stromal DCs or be internalized into the endocytic compartments ofDCs and pass from the stromal DCs to CD4+ T cells across an infectious synapse (see also Figure 4) where massive productiveinfection of CD4+ T cells ensues. In addition, virions can productively infect resting mucosal CD4+ memory T cells in the stromaand possibly stromal macrophages. f | Productively infected CD4+ T cells and stromal DCs, and stromal DCs or intraepithelialLCs harboring virions in endocytic compartments, can emigrate into the submucosa and the draining lymphatic and venousmicrovessels. CCR5, CC-chemokine receptor 5; DC-SIGN, dendritic-cell-specific ICAM3-grabbing non-integrin.| ADVANCe ONlINe pUblICATION /reviews/immunol©2008Nature Publishing GroupNature Reviews | Immunology DesmosomesNucleusBasal cell layera200nm2µmStromal papillaeSuperficial areas of themucosal stroma that interdigitate with the epithelium.C-type lectin receptorsA large family of receptors that bind glycosylated ligands and have multiple roles, such as in cell adhesion, endocytosis, natural-killer-cell targetrecognition and dendritic-cell activation.R5-tropic HIV-1An HIV strain that uses CC-chemokine receptor 5 (CCR5) as the co-receptor to gain entry to target cells.HIV encounters CD4+ T cells as well as lCs. lCs have dendrites that extend and retract through the intercel‑lular spaces 31, and which can even reach up to the surface of the epithelium 32, where HIV can bind directly to them (T. Hope, personal communication). based on observa‑tions of gut DCs 33,34, this could also be particularly true for DCs that are located just beneath the endocervical columnar epithelium. However, direct sampling of luminal pathogens by endocervical DCs or vaginal lCs, which could be exploited by HIV to bypass the epithelial‑cell barrier, has not yet been formally demonstrated. Mechanical micro‑abrasions of the mucosal surface induced by intercourse may also allow HIV to directly access target cells, such as DCs, T cells and macrophages, at the basal epithelium and the underlying stroma 35. Areas above the stromal papillae , where the epithelium is relatively thin and where lCs on the epithelial‑cell side (F.H., l. ballweber and M.J.M., unpublished observa‑tions) and T cells and macrophages on the stromal side 28 congregate, appear particularly vulnerable to viral inva‑sion. Consistent with this notion, in vivo simian immu‑nodeficiency virus (SIV) infection of the genital mucosa of macaques is initially established in a highly focal man‑ner, and continuous seeding from this nidus of infection is crucial for establishing systemic infection 17. Similarly, chemical micro‑abrasions from the use of certain topical microbicides and micro‑abrasions due to genital ulcers caused by sexually transmitted diseases (for example, syphilis, chancroid and those caused by herpes simplex virus) are also likely to result in the exposure of vulnerable target cells in the basal epithelium and stroma 36.Importance of cervicovaginal LCs in HIV invasion. For many years, HIV‑1 invasion of the lower genital tract has been assumed to occur through the internalization of HIV‑1 by lCs. This view was supported by evidence that skin lCs are susceptible to infection by HIV‑1 (REFS 37–40) and that genital mucosal lCs harbour SIV virions within 24 hours of intravaginal inoculation of macaques 30. However, soon after ex vivo organ culture, lCs migrate out of the epithelium 14,23,41–43; therefore, examination of lC infection specifically within the human vaginal epithelium has been technically difficult. For example, one landmark study demonstrated that after exposure of complete cervical mucosa from humans to HIV‑1, emigrating DCs had efficiently captured HIV and were capable of transmitting the virus in trans 42. However, it was not possible to determine whether the cells originated from the epithelium as lCs or from the underlying stroma as DCs. More recently, we resolved this issue by preparing sheets of vaginal epithelium separated from the underlying stroma, and observed that vaginal lCs efficiently internalized HIV‑1 into their cytoplasmic compartments 25. As lCs exit the epithelium at the basal side, they transport intact virions, thereby enabling the infection to spread beyond the site of viral entry (FIG. 2). However, it is not clear if lCs in the cervicovaginal epithelium can produce and release new HIV‑1 virions. HIV receptors expressed by these lCs include CD4, CCR5 and the C-type lectin receptor langerin (also known as CD207), but not CXCR4 and DC‑specific ICAM3 (inter‑cellular adhesion molecule 3)‑grabbing non‑integrin (DC‑SIGN; also known as CD209)25,44–47. Antibodies that bind CD4 and CCR5 partially block the uptake of R5-tropic HIV-1 by lCs, but blocking the binding of HIV‑1 to C‑type lectin receptor with mannan, a mannose polymer, had little effect on uptake 25. Although low‑level CD4‑ and CCR5‑mediated productive infection of lCs by HIV‑1 in human skin explants has been shown 39,40,48, we were unable to confirm this finding in our imaging studies of vaginal lCs 25. Therefore, if de novo production of virions occurs, it appears relatively inefficient in con‑trast to the high capacity of vaginal lCs to endocytose HIV‑1. Nevertheless, even low levels of productive HIV‑1 infection of cutaneous DCs and lCs lead to profound viral replication in co‑cultured T cells 40,48,49. Therefore, future investigations must conclusively determine if lCs in cervicovaginal epithelium can support productive HIV infection in vivo and if this property is required for the passage of the virus to T cells, as has been reported for other types of DC 50–53.The relative inefficiency of mannan in blocking the binding and endocytosis of HIV‑1 by vaginal lCs was sur‑prising 25 because C‑type lectin receptors, which recognize mannose‑containing carbohydrate structures, mediate viral entry in other types of DCs 46. However, HIV‑1 can bind DC subsets independent of C‑type lectin receptors and CCR5 (REFS 54–56). So, although HIV virions can efficiently bind to langerin expressed by epidermal lCs for their entry into these cells 57, they appear to largely bypass binding to langerin expressed by vaginal lCs in favour of alternative endocytic routes. This distinction may be highly relevant for mucosal HIV transmission.Figure 3 | HiV-1 transcytosis in situ in the vaginal epithelium. Electron micrographshowing a vaginal epithelial cell located one layer above the basal cell layer andcontaining intact cytoplasmic virions following 24 hours of infection with HIV-1BaL (a procedure performed on vaginal epithelial sheets, as previously described 25) (a ). As shown in the higher power insets, the virions can be seen on both the apical (b ) and basal (c ) sides of the nucleus, signifying transcytosis. Desmosomes and keratin fibres,distinguishing features of the epithelial cell, can also be seen (c ).NATURe ReVIeWS | immunologyADVANCe ONlINe pUblICATION |© 2008Nature Publishing GroupBirbeck granules Membrane-bound rod- or tennis-racket-shaped structures with a central linear density, found in the cytoplasm of Langerhans cells. Their formation is induced by langerin, an endocytic C-type lectin receptor that is specific to Langerhans cells. PhagosomesVacuolar compartments that confine microorganisms after enforced endocytosis orafter phagocytosis. Unless counteracted by a microbial survival strategy, the phagosome matures into a hostile environment that is designed to kill and digest microorganisms.Cross-presentationThe initiation of a CD8+ T-cell response to an antigen that is not present within antigen-presenting cells (APCs). This exogenous antigen must be taken up by APCs and then re-routed to the MHC-class-I pathway of antigen presentation.Lamina propria Connective tissue that underlies the epithelium of the mucosa and contains various myeloid and lymphoid cells, including macrophages, dendritic cells, T cells andB cells. langerin expressed by epidermal lCs can direct HIV‑1to Birbeck granules for degradation57. by contrast, by gain‑ing entry to the vaginal lCs independently of langerin,HIV may survive by reaching endocytic compartments,such as early phagosomes, where antigens are preservedfor cross-presentation58. This is consistent with our observa‑tions that intact virions were still present in lCs that hadmigrated out of the vaginal epithelium 60 hours after viralchallenge25. Therefore, it appears that HIV‑1 enters vaginallCs through a different route than when it enters skin lCs,and this results in a distinct fate of the endocytosed viri‑ons. More detailed studies are now warranted to uncoverwhich endocytic pathways HIV uses in vaginal lCs, andhow this can be harnessed therapeutically.Infection of DCs in the cervicovaginal stroma. Unlikegenital lCs, stromal DCs express both DC‑SIGN46,47and CCR5 (REFS 59,60) and have been implicated inSIV and HIV infection, but their exact role in mucosaltransmission is not clear. In situ studies in the humanexplant model have failed to identify infected DCs in thecervicovaginal stroma14,23,41,43. by contrast, SIV‑infectedDCs were present in the lamina propria of the cervico‑vaginal mucosa of macaques shortly after intravaginalSIV challenge30,61, as well as in chronically infected ani‑mals62. likewise, HIV‑infected DCs were identified intissue biopsies of the vaginal stroma of asymptomaticHIV‑1‑infected women63.The failure to identify infection of stromal DCs in thehuman explant models might be attributable to the rela‑tively low sensitivity of the detection methods used andthe migration of stromal DCs from the tissue, which maydrastically decrease the number of infected cells in situover time. Indeed, when DCs were harvested from theculture supernatants of human cervical explants that werechallenged with HIV‑1, significant in trans infectivity wasdetected42 and massive budding of virions was observedamong emigrant DCs 5 days after virus exposure60(FIG. 4).However, it could not be determined if the original sourceof DCs was from the epithelium proper or from the stro‑mal tissue. In addition, inferring the initial susceptibilityof DCs while confined to the mucosal stroma, based onfindings from emigrated DCs that undergo phenotypicchanges as they exit the mucosa, may be less reliable.Therefore, stromal DCs exhibit different HIV‑1 recep‑tor expression patterns compared with lCs, potentiallypermitting different HIV‑1 entry pathways. Much stillremains to be learned about stromal DCs in the humangenital mucosa in general, whether different subsets existsimilar to those found in skin dermis64, and the interactionof these DC subsets with HIV virions in particular. Moresensitive in situ detection methods of HIV infection, aswell as assays that can distinguish de novo virus produc‑tion from endocytically engulfed virions, as recentlyreported65, will be helpful in determining the exactcontribution of stromal DCs to the propagation of HIV.HIV infection of cervicovaginal CD4+ T cells. CD4+T cells are dispersed throughout the lamina propria ofthe human vagina, ectocervix and endocervix, oftenclustering just beneath the basal membrane66,67. They arealso found at variable numbers within the vaginal andectocervical squamous epithelium66,67. The majority ofthese cells are memory T cells that express higher levelsof CCR5 than those that circulate in the blood25,68–70. Oneday after HIV‑1 inoculation of vaginal, ectocervical andendocervical tissue cultures, infected CD4+ T cells wereshown to be confined to the mucosal stroma14,16,23,42.This result was surprising, given the presence of CCR5+CD4+ T cells within the squamous epithelium. However,by analysing the fate of fluorescently tagged virions asearly as 2 hours after viral exposure, we observed thatR5‑tropic HIV‑1 efficiently bound to intraepithelialvaginal CD4+ T cells, and this was followed by fusionand productive infection25. Therefore, infected T cellsmust rapidly leave the epithelium, and those found inthe stroma may be the same or the early progeny ofintraepithelial T cells.Findings in the human explant studies show thatHIV‑1 very effectively targets CD4+ T cells in thegenital mucosa for productive infection14,25,42, and thatthe initial infection of intraepithelial CD4+ T cells isprobably independent of lCs25. The central role forgenital CD4+ T cells in early infection and propaga‑tion is also evident from SIV challenge experimentsin macaques62,71,72. Interestingly, not only does SIVproductively infect activated T cells, characterized byHlA‑DR and Ki67 expression, it also infects T cells thatare in the resting state (HlA‑DR– and Ki67– T cells)71.Consistent with this finding, we observed binding ofHIV‑1 to both HlA‑DR+ and HlA‑DR– intraepithelialT cells in our human vaginal explant model (M.J.M.,p. Sakchalathorn, l. ballweber and F.H., unpublishedobservations). In addition, the contribution of restingCD4+ T cells to viral production is substantial duringthe very earliest stages of infection73. The fact that vagi‑nal CD4+ T cells are rapidly depleted following intra‑venous SIV inoculation of macaques5,72, similar to thedepletion of CD4+ T cells in the gut during acute SIVinfection74, further illustrates their high susceptibilityto infection in vivo.Other leukocyte HIV targets in the female genital tract.Macrophages in the female genital mucosa are alsosusceptible targets for early HIV‑1 infection, as demon‑strated in studies using human cervical explant mod‑els23,41,43, and in two reports these cells were the major celltype that was infected by R5‑tropic HIV‑1 (REFS 23,43).Whether or not resident macrophages in the femalegenital tract constitutively express CCR5 in situ is notknown, but most macrophages do so when harvestedfrom supernatants of vaginal organ cultures60, suggestingthat the expression of CCR5 by macrophages may occurduring the period of activation and emigration fromthe mucosa75. by contrast, SIV‑infected macrophagesin genital tissues were either rare71, or undetectable30,61.likewise, macrophages in the human intestinal mucosawere reported to lack CCR5 expression and to possesslow permissibility to HIV‑1 infection76. These discrep‑ancies illustrate a potential limitation of organ cultures.If explantation activates stromal macrophages and as aconsequence increases surface CCR5 expression, this| ADVANCe ONlINe pUblICATION /reviews/immunol©2008Nature Publishing Group。
DC-SIGN的固有信号决定免疫应答
摘要:有效地免疫应答依赖于树突状细胞通过模式识别受体对病原体的识别。
这些受体诱发信号途径导致免疫系统对病原体的抵抗作用。
越来越多的证据证明C型凝集素也是重要的模式识别受体。
特别是DC-SIGN通过调节TLR在对多种病原体免疫应答中起着重要作用。
通过与病原体结合,DC-SIGN在诱导胞内信号途径时raf-1发挥中心作用。
由于一些病原体可以与DC-SIGN相互作用,包括结核分枝杆菌,HIV-1,Raf-1激活作用使NF-kb的亚基p65乙酰化,而此亚基可以诱导特定的基因转录谱。
此外,其他DC-SIGN配体诱导Raf-1下游不同的信号途径,来决定DC-SIGN信号对病原体的针对性。
在此综述中,我们详细讨论DC-SIGN信号及其在免疫学中的作用。
引言:有效地免疫应答依赖于DC表面的PRR对病原体表面的PAMPs的识别结合,PAMPs 对病原体生存来说非常重要,比如细菌或真菌胞壁成风病毒或细菌的核酸。
DC表面也具备不同的PRR以来识别病原体表面的不同的PAMP。
PRR主要有TLR,NODLR,CARD解螺旋酶。
这些受体的激活可以诱导调节编码免疫共刺激分子、细胞因子和趋化因子的反应基因的表达的受体特异性胞内信号。
大多数病原体表面表达不同的PAMPs同时引起单个细胞表面的多类PRRs。
结果一种病原体引起的多种信号途径的综合作用诱使最终反应基因表达。
事实上,这种信号间的串话调节通过正反馈或者负反馈机制的共同诱导对平衡免疫应答至关重要。
最近几年,C型凝集素在诱导对多种病原体的免疫应答方面成为重要的PRR。
C型凝集素DC-SIGN和DC-SIGN相关C型lectin-1都可以诱导多种病原体的免疫应答。
C型凝集素诱导的胞内信号途径可以调节其他PRR如TLR,但是它发挥作用也依赖其他的PRR。
DC-SIGN可与多种病原体相互作用如细菌真菌病毒。
虽然我们知道DC-SIGN在免疫应答又道方面起着重要的作用,前些年,对暗含在DC-SIGN功能下的分子机制仍难以琢磨。
dendritic cell名词解释
dendritic cell名词解释
树突状细胞(dendritic cell,DC)是机体免疫系统中最强有力的一种专职的抗原呈递细胞(APC),在免疫应答的启动、调控中起着关键的作用。
树突状细胞(dendritic cell,DC)是免疫系统中一类强有力的抗原提呈细胞,在始动机体免疫反应中起着至关重要的作用,可刺激B细胞及T细胞发生免疫反应。
DC于1973年首次由Steinman发现,因其表面有众多树状突起而得名。
树突状细胞(dendritic cell, DC),存在于血液和暴露于环境的组织中,如皮肤和鼻子、肺、胃和小肠的上皮组织。
它是一种专业的抗原提呈细胞,通过对T、B淋巴细胞的抗原加工和提呈,将先天免疫和适应性免疫联系起来[11,12]。
树突状细胞的常规标记物包括CD11c、BDCA-1/2以及CD123[13],树突状细胞主要分为三类:浆细胞样树突状细胞(pDC),专精于识别病毒和肿瘤细胞。
I型经典树突状细胞(cDC1),能够识别细胞内病原体并触发CD8 T 细胞和Th1 CD4 T细胞应答。
II型经典树突状细胞(cDC2),在与细胞内病原体、寄生虫、变应原、真菌和细胞外细菌接触时,会触发CD4 T细胞反应。
树突状细胞在新型冠状病毒感染中的功能和机制
树突状细胞在新型冠状病毒感染中的功能和机制①范志国吴忌古源楷陈娟刘娟(海军军医大学免疫学研究所暨免疫与炎症全国重点实验室,上海 200433)中图分类号R392.12 R392.32 R563.1 文献标志码 A 文章编号1000-484X(2023)11-2420-08[摘要]新型冠状病毒(SARS-CoV-2)引发的新型冠状病毒肺炎(COVID-19)肆虐全球,给人类健康和公共卫生安全带来巨大伤害。
免疫系统与病毒的相互作用决定了人体对新冠病毒的易感程度和病情转归。
树突状细胞(DCs)作为机体功能最为强大的抗原提呈细胞,是天然免疫和适应性免疫的核心桥梁。
DCs在机体抵抗新冠病毒感染的免疫应答过程中发挥重要作用,既是抗病毒免疫防御的关键成分,又可能介导免疫病理的发生。
本文将阐述DCs在SARS-CoV-2免疫应答中的变化及发挥的功能,探讨DCs在新冠肺炎不同病程阶段的作用机制,并讨论相关研究对破解新冠肺炎新型发病机制和寻找潜在临床靶标中的意义。
[关键词]新型冠状病毒;树突状细胞;抗病毒免疫;干扰素;炎症因子Dendritic cells in host immunity to SARS-CoV-2 and mechanismsFAN Zhiguo, WU Ji, GU Yuankai, CHEN Juan, LIU Juan. National Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai 200433, China[Abstract]COVID-19 caused by SARS-CoV-2 has caused great harm to human health and public security. Interaction between immune system and virus determines host susceptibility to SARS-CoV-2 infection and clinic outcome of COVID-19. Dendritic cells (DCs), as the most potent antigen-presenting cells, are core bridge linking innate and adaptive immunity. DCs play a flexible role in shaping immune response against COVID-19 infection, acting both as essential components of antiviral immune defense and also as potential mediators of immunopathology. In this review article,we will describe changes and functions of DCs during SARS-CoV-2 infection, and discuss involvement of DCs in pathogenesis of COVID-19 and its potential as disease biomarkers or targets.[Key words]SARS-CoV-2;Dendritic cells;Anti-viral immunity;Interferon;Inflammatory cytokines新型冠状病毒(SARS-CoV-2)引起的新型冠状病毒肺炎(COVID-19)疫情持续不断地蔓延至全球。
通用、肺癌血清、 肝癌血清、胃癌血清、卵巢癌血清、结直肠癌、前列腺癌血清等肿瘤标志物及临床意义解读
通用、肺癌血清、肝癌血清、胃癌血清、卵巢癌血清、结直肠癌、前列腺癌血清等肿瘤标志物及临床意义解读肿瘤标志物是指在恶性肿瘤发生和增殖过程中,由肿瘤细胞的基因表达而合成分泌的或由机体对肿瘤反应而异常产生和升高的,反映肿瘤存在和生长的一类物质。
TM 对肿瘤的存在具有重要的提示意义,越来越多的血液 TM 成为肿瘤早期诊断研究的热点引起关注。
常见通用TMCEA(癌胚抗原)是传统的非特异广谱 TM,正常值≤ 5 ng/mL,CEA 诊断肺腺癌阳性率最高达 80%以上。
升高还可见于大肠癌、胰腺癌、胃癌、乳腺癌等,可用于监测肿瘤的复发和转移。
>>>> CA125(糖类抗原 125)正常值:0.1 ~ 35 U/mL;CA125 是卵巢癌和子宫内膜癌的首选标志物,而且在非小细胞肺癌中阳性率高。
轻度升高可见于多种良性疾病,如卵巢肿瘤、子宫肌瘤、宫颈炎、肝硬化及肝炎等。
CA199(糖类抗原 19-9)正常值:0.1 ~ 27 U/mL;是胰腺癌、胃癌以及结直肠癌、胆囊癌的相关标志物CA15-3(糖类抗原 15-3)正常值:< 28 ng/mL;是乳腺癌辅助诊断(初期敏感性 60%,晚期敏感性 80%)、术后随访和转移复发的指标之一。
在肺癌、结肠癌、胰腺癌、卵巢癌、原发性肝癌中也可见升高。
SCC(鳞状上皮细胞癌抗原)正常值:< 1.5 ug/L;是鳞状细胞癌的肿瘤标志物,可用于宫颈癌、肺鳞癌、食管癌、头颈部癌、膀胱癌的辅助诊断,治疗观察和复发监测。
NSE(神经元特异性烯醇化酶)正常值:< 16.3 ng/mL;是小细胞肺癌的肿瘤标志物(诊断阳性率 91%),还可用于其疗效观察和复发监测。
神经母细胞瘤、神经内分泌细胞瘤的血清 NSE 浓度也可明显升高。
肺癌血清TMPro-GRP(胃泌素前体释放肽片段)大于 24 ng/L 时,高度怀疑肺部肿瘤,针对小细胞肺癌的特异性非常高,在较早期病例有较高的阳性率(敏感性达 50.3%)。
DENDRITIC CELL-SPECIFIC ANTIBODIES
专利名称:DENDRITIC CELL-SPECIFIC ANTIBODIES 发明人:HART, DEREK, NIGEL, JOHN,VUCKOVIC, SLAVICA申请号:EP00981083申请日:20001201公开号:EP1237929A4公开日:20040428专利内容由知识产权出版社提供摘要:The present invention relates generally to immuno-interactiveimmuno-interactive agents which are capable of interacting with an epitope on a molecule in or on dendritic cells (DC). More particularly, the present invention provides immunological reagents such as but not limited to immunoglobulin agents which are capable of interacting with an epitope on a molecule present on or within a subset of DC. Generally, the DC are a subset of DC which have been subjected to differentiation stimulus. The resulting differentiated, activated subset of DC produce a molecule comprising an immunologically detectable epitope which is not detectable in non-differentiated DC. The present invention further relates to cell lines which produce the instant immuno-interactiveimmuno-interactive molecules and to a method for identifying and purifying the above-mentioned subset of DC from a biological sample such as blood using the instant immuno-interactiveimmuno-interactive molecules. The present invention further provides for modulators of the interaction between the instant immuno-interactiveimmuno-interactive molecules and an epitope to which they bind. These modulators are useful in controlling an immune response. The present invention further provides an antigenic molecule or part thereof or cell preparation comprising same whichis capable of interacting with the subject immuno-interactiveimmuno-interactive agents. The present invention is further directed to the use of the subject immuno-interactive molecules and/or modulators thereof in the manufacture of medicaments for use in immunomodulation and immunotherapy. An immuno-interactive molecule includes an antibody, fragments thereof and recombinant synthetic or hybrid forms of antibodies.申请人:THE CORPORATION OF THE TRUSTEES OF THE ORDER OF THE SISTERS OF MERCY IN QUEENSLAND更多信息请下载全文后查看。
DC-SIGN真核表达载体的构建及其稳定转染BHK21细胞系的建立
DC-SIGN真核表达载体的构建及其稳定转染BHK21细胞系的建立王宇;阎瑾琦;张亮;王越;于继云【摘要】目的构建DC-SIGN分子真核表达载体,获得可稳定表达DC-SIGN分子的BHK21细胞系.方法以pUNO-hDC-SIGN1Aa质粒为模板,通过PCR方法扩增人DC-SIGN基因,经过Not Ⅰ和BamH Ⅰ双酶切之后,将其克隆入真核表达载体pIRES-neo,构建真核表达载体pIRES-neo-DC-SIGN,以Not Ⅰ和BamH Ⅰ双酶切以及测序验证重组质粒的正确性.将重组质粒以Lipo-fectamine~(KM) 2000转染到BHK21细胞,通过G418及有限稀释法进行阳性克隆的筛选,建立稳定表达DC-SIGN分子的BHK21细胞系,利用流式细胞仪、Western blotting及免疫荧光法检测DC-SIGN分子的表达.结果双酶切鉴定证明DC-SIGN基因已经成功克隆入真核表达载体pIRES-neo中,测序结果表明EC-SIGN基因与原序列一致.pIRES-neo-DC-SIGN转染BHK21细胞后,获得了急定表达DC-SIGN分子的细胞系.流式细胞仪检测结果显示,阳性克隆中DC-SIGN分子的表达率为85.42%.免疫荧光结果显示,DC-SIGN分子主要表达于细胞膜表面.Western blotting能检测到DC-SIGN 蛋白表达的特异条带.结论成功构建了稳定、高效表达DC-SIGN分子的BHK21细胞系,为后续DC靶向性疫苗研究奠定了基础.【期刊名称】《解放军医学杂志》【年(卷),期】2010(035)003【总页数】3页(P304-306)【关键词】基因,DC-SIGN;BHK21细胞系;树突细胞【作者】王宇;阎瑾琦;张亮;王越;于继云【作者单位】100850,北京,军事医学科学院基础医学研究所;100850,北京,军事医学科学院基础医学研究所;100850,北京,军事医学科学院基础医学研究所;100850,北京,军事医学科学院基础医学研究所;100850,北京,军事医学科学院基础医学研究所【正文语种】中文【中图分类】R349.8DC-SIGN(DC specific intercellular-adhesion-molecule-3 grabbing nonintegrin)主要表达于不成熟的树突细胞(dendritic cells,DCs)表面[1],参与DCs 摄取抗原,多种病毒都能以DC-SIGN为受体侵入细胞[2]。
DC-SIGN固有免疫调节机制的研究进展
DC-SIGN固有免疫调节机制的研究进展王舒煜;王家凤;武玉凤;刘畅;张志民【摘要】树突状细胞(DC)是目前已知功能最强的抗原呈递细胞.它既可以激活初始免疫应答,又能够抑制免疫反应,这与其表达的多种模式识别受体有关,其中DC-SIGN是C型凝集素受体的主要成员,由于它在DC的细胞粘附、迁移、激活初始T 细胞、引发免疫反应及参与病原体免疫逃逸等多个方面发挥免疫调节作用,已经成为近年来的研究热点,对其功能的研究可能会为某些疾病提供新的治疗方法,具有重要的临床意义.本文就DC-SIGN免疫调节机制的最新进展做一综述.%It is well known that dendritic cells are the most potent antigen presenting cells. They can activate primary immune response, but also downregulate immune response, which relates with a variety of pattern recognition receptors expressed by them. DC-SIGN (DC-specific ICAM-3-grabbing nonintegrin, CD209) is primary member of the C-type lectin receptors. In recent years, DC-SIGN has received great attention due to its important role in immunological regulation such as mediating cell adhesion, migration, activating primary T cells, triggering the immune response and im-mune escape of pathogens. The study of DC-SIGN can provide us with a new method in treating certain diseases and have important clinical significance. This article reviews the latest advances in DC-SIGN immunoregulatory mechanisms.【期刊名称】《海南医学》【年(卷),期】2017(028)014【总页数】4页(P2323-2326)【关键词】树突状细胞;DC-SIGN;免疫调节;机制【作者】王舒煜;王家凤;武玉凤;刘畅;张志民【作者单位】吉林大学口腔医院牙体牙髓病科,吉林长春 130021;吉林大学口腔医院牙体牙髓病科,吉林长春 130021;吉林大学口腔医院牙体牙髓病科,吉林长春130021;吉林大学口腔医院牙体牙髓病科,吉林长春 130021;吉林大学口腔医院牙体牙髓病科,吉林长春 130021【正文语种】中文【中图分类】R392树突状细胞(dendritic cells,DC)的功能强大,负责产生抗原特异性免疫应答,用于诱导耐受性,并维持免疫内环境的稳定。
DC-SIGN诱导的信号通路在HIV-1前病毒活化中的作用
DC-SIGN诱导的信号通路在HIV-1前病毒活化中的作用李杰;靳昌忠;程林芳;刘福民;吴南屏【摘要】Objective To explore the mechanism of latent human immunodeficiency ciency virus type 1 (HIV-1) infection is unclear, especially in dendritic cells (DC).We hypothesized that DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) binds with HIV-1 may activate HIV-1 provirus.Methods We generated a model by transfecting 293T cells with a DC-SIGN expression plasmid and a HIV-15'long terminal repeat (LTR) reporter plasmid, and then stimulated the 293T cells with HIV-1 gp120 protein, wild-type HIV-1 and VSV-G-pNL4.3 pseudotype virus ( without gp120 protein).CEM-Bru cells were transfected with the DC-SIGN expression plasmid and stimulated by HIV-1 gp120 protein.Then HIV-1 replication was detected.The involvement of the ERK, p38 and NF-κB pathways signaling in this response were determined by inhibiting the pathways specifically and detecting the phosphorylation of the signaling kinase.Results The HIV-1 5'LTR was reactivated by HIV-1gp120 in DC-SIGN-expressing 293T cells.After HIV-1 gp120 protein stimulation of the mold of CEM-Bru cells, the increasing expression of HIV-1 Tat mRNA and HIV-1 p24,which implies early and late HIV-1 provirus replication was reactivated by the HIV-1 gp120/DC-SIGN stimulation.HIV-1 gp120/DC-SIGN stimulation reactivates latent HIV-1 provirus via the NF-κB signal pathway.Conclusion HIV-1 gp120/DC-SIGN stimulation reactivates latent HIV-1 provirus via the NF-κB signal pathway.%目的:研究HIV-1gp120蛋白与DC-SIGN结合对HIV-1前病毒的活化作用及其信号通路机制。
DC-SIGN与微生物感染研究进展
DC-SIGN与微生物感染研究进展李军;冯志华【期刊名称】《世界华人消化杂志》【年(卷),期】2005(13)5【摘要】树突状细胞(DC)在抵御病原体的过程中至关重要.然而, 近来的研究表明,一些病原体破坏了DC的功能以逃脱免疫监视.许多细胞表面分子与病毒包膜糖蛋白结合后并不介导病毒抗原的加工和呈递,相反,他们可作为捕获受体将病毒颗粒传递给靶器官或敏感细胞.HIV-1就可与DC特异的C型凝集素DC-SIGN(Dc specific intercellular—adhesion—molecule-3 grabbing nonintegrin,树突状细胞特异性细胞间黏附分子-3结合非整合素因子;即CD209)结合,“绑架”C,感染宿主.DC—SIGN除了可与HIV-1、HCV结合外, 还可与其他多种病原体结合.对病原体和DC—SIGN的相互作用以及对DC功能的进一步研究,必将有助于抗感染的治疗.本文就DC—SIGN与微生物感染的研究进展作一综述.【总页数】5页(P662-666)【关键词】DC;感染研究;细胞间黏附分子-3;molecule;HIV-1;细胞表面分子;树突状细胞;C型凝集素;细胞特异性;微生物感染;病原体;病毒抗原;蛋白结合;免疫监视;敏感细胞;病毒颗粒;相互作用;靶器官;整合素;HCV;步研究;抗感染【作者】李军;冯志华【作者单位】中国人民解放军第四军医大学唐都医院【正文语种】中文【中图分类】R392.11;R764【相关文献】1.DC-SIGN/DC-SIGNR基因多态性与病原微生物感染 [J], 许利军;潘晨;李勤光2.DC-SIGN与病原体感染的研究进展 [J], 刘旭东;李刚3.DC-SIGN与微生物感染的研究进展 [J], 陈莉;孟秀娟;李聪智4.DC-SIGN在病毒感染中的作用机制研究进展 [J], 张莉5.DC-SIGN与HIV感染的相关性研究进展 [J], 吕佰瑞;刘朝奇因版权原因,仅展示原文概要,查看原文内容请购买。
DC-SIGN基因多态性及表达差异与宿主易感性之间的关系
DC-SIGN基因多态性及表达差异与宿主易感性之间的关系张劼;郭述良;罗永艾【期刊名称】《国际内科学杂志》【年(卷),期】2009(36)3【摘要】树突状细胞(DCs)是体内功能最强的抗原呈递细胞,其表面的DCs特异性细胞间黏附分子-3结合非整合素因子(DC-specific ICAM-3 grabbing nonintegrin,DC-SIGN)一方面可介导DCs对病原体的结合和抗原呈递,有利于宿主免疫应答;另一方面也可被胞内寄生病原体利用,协助其感染宿主T细胞,并通过干扰DCs成熟来影响其抗原呈递能力,抑制宿主免疫功能.目前研究认为,DC-SIGN基因多态性及表达差异可能会影响宿主对病原体的易感性.【总页数】4页(P175-178)【作者】张劼;郭述良;罗永艾【作者单位】重庆市第三人民医院老年科,重庆,400014;重庆医科大学附属第一医院呼吸内科,重庆,400016;重庆医科大学附属第一医院呼吸内科,重庆,400016【正文语种】中文【中图分类】R5;R392【相关文献】1.中国汉族人群Toll样受体2基因多态性与肺结核易感性之间关系 [J], 车南颖;姜世闻;高铁杰;李松;张旭霞;张慧;张治国;王黎霞;李传友2.中国汉族人群Toll样受体2基因多态性与肺结核易感性之间关系 [J], 车南颖;姜世闻;高铁杰;李松;张旭霞;张慧;张治国;王黎霞;李传友3.MBL基因多态性与结核病易感性之间的关系 [J], 郭洋; 刘宁; 于丹; 卜祥玉; 王秀秀4.亚甲基四氢叶酸还原酶基因多态性和疾病易感性之间的关系 [J], 周琰; 潘柏申; 郭玮5.人白细胞抗原-G基因多态性与脑胶质瘤易感性之间的关系 [J], 赵开胜; 折盼; 白利芬因版权原因,仅展示原文概要,查看原文内容请购买。
C型凝集素受体DC--SIGN在特应性皮炎发病中的作用机制研究的开题报告
C型凝集素受体DC--SIGN在特应性皮炎发病中的作用机制研究的开题报告摘要:C型凝集素受体DC-SIGN是一种表达在DC和巨噬细胞表面的重要膜分子,具有介导病原体和肿瘤细胞识别和清除、调节免疫活性等多种功能。
最近的研究表明,DC-SIGN可能在特应性皮炎(Atopic dermatitis,AD)中也发挥了非常重要的作用。
然而,目前关于DC-SIGN在AD中的作用机制研究仍然较为有限和不完善,因此有必要深入探讨DC-SIGN在AD病理生理过程中的具体作用机制。
本文将以文献回顾的方式,结合目前的研究进展,系统地阐述DC-SIGN在AD中的潜在作用机制,包括:(1)DC-SIGN介导过敏原和炎症介质清除和抗原递呈;(2)DC-SIGN调控TH2细胞和TH17细胞的分化及其相关细胞因子表达;(3)DC-SIGN介导肠道菌群与AD的关联。
本文对DC-SIGN在AD的发病过程中的作用机制进行探讨,将有助于深入了解AD的发生机制,提高对该疾病的治疗和预防水平。
关键词:C型凝集素受体DC-SIGN;特应性皮炎;发病机制;病理生理过程;作用机制Introduction:特应性皮炎(Atopic dermatitis,AD)是一种常见的慢性炎症性皮肤病,多数发病于儿童期,其特征性症状包括皮肤瘙痒、干燥、疹子等。
AD的病因十分复杂,除了遗传因素外,外界的诱因(如过敏原、环境因素、细菌感染等)也起到至关重要的作用。
C型凝集素受体DC-SIGN是一种广泛表达在DC和巨噬细胞表面的重要膜分子,其除了参与介导病原体和肿瘤细胞的识别和清除外,还能够调节免疫反应、递呈抗原等。
研究发现,DC-SIGN在AD的发病过程中也扮演了重要角色。
目前有关DC-SIGN在AD中作用机制的研究尚不完全,因此对其进行深入探讨将对AD的发生和发展有非常重要的意义。
Materials and methods:本文将通过文献检索方法,利用PubMed、Web of Science等数据库,收集有关DC-SIGN在AD中的相关研究。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Cell,Vol.100,587–597,March 3,2000,Copyright ©2000by Cell PressDC-SIGN,a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans -Infection of T Cellsvague,but based on anatomical distribution of different hematopoietic lineage cells and on in vitro infectivity studies it has been inferred that immature dendritic cells (DC)residing in the skin and at mucosal surfaces are the first cells targeted by HIV-1.DC are the most potent Teunis B.H.Geijtenbeek,*Douglas S.Kwon,§Ruurd Torensma,*Sandra J.van Vliet,*Gerard C.F.van Duijnhoven,*Jeena Middel,‡Ine L.M.H.A.Cornelissen,†Hans S.L.M.Nottet,‡Vineet N.KewalRamani,§Dan R.Littman,§ antigen-presenting cells in vivo (Valitutti et al.,1995;Carl G.Figdor,*and Yvette van Kooyk*#Banchereau and Steinman,1998).Immature DC in pe-*Department of Tumor Immunology ripheral tissues capture antigens efficiently and have †Department of Pathologythe unique capacity to subsequently migrate to the T University Medical Center St.Radboud cell areas of secondary lymphoid organs.As the cells Philips van Leydenlaan 25travel,they mature and alter their expression profile of Nijmegen 6525EX cell surface molecules,including chemokine receptors,The Netherlandslose their ability to take up antigen,and acquire compe-‡Eykman-Winkler Institute of Microbiology tence to attract and activate resting T cells in the lymph University Hospital Utrecht nodes (Adema et al.,1997;Banchereau and Steinman,Heidelberglaan 1001998).HIV-1is thought to subvert the trafficking capacity 3584CX Utrecht of DC to gain access to the CD4ϩT cell compartment The Netherlandsin the lymphoid tissues (Grouard and Clark,1997;Row-§Skirball Institute of BioMolecular Medicine land-Jones,1999;Steinman and Inaba,1999).and Howard Hughes Medical Institute Immature DC express CD4and CCR5,albeit at levels New York University Medical Center that are considerably lower than on T cells (Granelli-New York,New York 10016Piperno et al.,1996;Rubbert et al.,1998),and they have been reported to be infectable with R5strains of HIV-1.In contrast,immature DC do not express CXCR4and Summaryare resistant to infection with X4isolates of HIV-1(Weissman et al.,1995;Blauvelt et al.,1997;Granelli-Dendritic cells (DC)capture microorganisms that enter Piperno et al.,1998).Entry of HIV-1into immature DC peripheral mucosal tissues and then migrate to sec-has also been reported to proceed through a CD4-inde-ondary lymphoid organs,where they present these pendent mechanism (Blauvelt et al.,1997),suggesting in antigenic form to resting T cells and thus initiate that receptors other than CD4could be involved.There adaptive immune responses.Here,we describe the have been conflicting reports regarding the significance properties of a DC-specific C-type lectin,DC-SIGN,of HIV-1replication within DC (Cameron et al.,1994;that is highly expressed on DC present in mucosal Ayehunie et al.,1997;Canque et al.,1999).Although tissues and binds to the HIV-1envelope glycoprotein replication can be observed in some circumstances,it gp120.DC-SIGN does not function as a receptor for has also been reported that,in immature DC,replication viral entry into DC but instead promotes efficient infec-is incomplete and that only early HIV-1genes are tran-tion in trans of cells that express CD4and chemokine scribed.receptors.We propose that DC-SIGN efficiently cap-It has been proposed that virus-infected immature DC tures HIV-1in the periphery and facilitates its transport migrate to the draining lymph nodes where they initiate to secondary lymphoid organs rich in T cells,to en-both a primary antiviral immune response and a vigorous hance infection in trans of these target cells.productive infection of T cells,allowing systemic distri-bution of HIV-1(Cameron et al.,1992;Weissman et al.,Introduction1995;Granelli-Piperno et al.,1999).However,in a nonhu-man primate model of mucosal infection with the simian Transmission of human immunodeficiency virus type 1immunodeficiency virus,it has been difficult to demon-(HIV-1)infection in humans requires the dissemination strate productive infection of DC despite rapid dissemi-of virus from sites of infection at mucosal surfaces to T nation of virus (Stahl-Hennig et al.,1999).Other efforts cell zones in secondary lymphoid organs,where exten-to model primary HIV-1infection in vitro by exposing sive viral replication occurs in CD4ϩT-helper cells DC derived from skin or blood to HIV-1have indicated (Fauci,1996).These cells express both CD4and the that these cells are poorly infected.Nevertheless,only chemokine receptor CCR5,which together form the re-DC and not other leukocytes,including monocytes,ceptor complex required for entry by the R5viral isolates macrophages,B cells,and T cells,were able to induce that are prevalent early after infection (Dragic et al.,high levels of infection upon coculture with mitogen-1996;Lu et al.,1997;Littman,1998).Viruses with tropism activated CD4ϩT cells after being pulsed with HIV-1for other chemokine receptors,particularly CXCR4,are (Cameron et al.,1992,1992b,1996;Weissman et al.,rarely transmitted and generally appear only late in in-1995;Blauvelt et al.,1997;Granelli-Piperno et al.,1999).fection.In an early study,Cameron et al.(1992)proposed that The mechanism of early viral dissemination remainsDC have a unique ability to “catalyze”infection of T cells with HIV but do not become infected themselves.The mechanism by which DC capture HIV-1and pro-#To whom correspondence should be addressed:(e-mail:y.vankooyk@dent.kun.nl).mote infection of CD4ϩT cells has not been elucidated,Cell588Figure1.DC-SIGN Is a DC-Specific Recep-tor for HIV-1gp120(A)DC-SIGN is expressed specifically by DC.Immature DC,cultured from monocytes in thepresence of GM-CSF and IL-4,express highlevels of DC-SIGN,whereas resting periph-eral blood lymphocytes and monocytes donot express DC-SIGN.Expression of DC-SIGN(AZN-D1)was determined by FACScananalysis.One representative experiment outof three is shown.(B)DC-SIGN,but not CD4,mediates bindingof HIV-1gp120to DC.DC were allowed tobind HIV-1gp120-coated fluorescent beads.Adhesion was blocked by anti-DC-SIGN anti-bodies(20g/ml),mannan(20g/ml),andEGTA(5mM),and not by neutralizing anti-CD4antibodies(20g/ml).One representa-tive experiment out of three is shown.(C)Immature DC express low levels of CD4(RPA-T4)and CCR5(2D7/CCR5)and high lev-els of DC-SIGN(AZN-D1).THP-1cells stablytransfected with DC-SIGN(THP-DC-SIGN)express high levels of DC-SIGN(AZN-D1)while CD4and CCR5are not expressed(filledhistograms).Antibodies against CD4and DC-SIGN were isotype matched,and the appro-priate isotype controls are represented bydotted lines.(D)DC-SIGN transfectants(THP-DC-SIGN)bind HIV-1gp120.THP-DC-SIGN and mocktransfectants were allowed to bind HIV-1gp120-coated fluorescent beads.Adhesionwas blocked by anti-DC-SIGN antibodies(20g/ml)and EGTA(5mM)and not by neutraliz-ing anti-CD4(RPA-T4)antibodies(20g/ml).One representative experiment out of threeis shown.and it has been unclear whether there is specificity in(Geijtenbeek et al.,2000).Flow cytometric analysis ofan extensive panel of hematopoietic cells with anti-DC-the interaction of DC with virus.In the accompanyingpaper,we describe the identification of a DC-specific SIGN antibodies demonstrated that DC-SIGN is prefer-C-type lectin,designated DC-SIGN,that binds with highentially expressed on in vitro cultured DC but not on affinity to ICAM-3present on resting T cells(Geijtenbeek other leukocytes,such as monocytes and peripheral et al.,2000[this issue of Cell]).Nucleotide sequenceblood lymphocytes(PBL)(Figure1A).Identification of analysis of the cDNA indicated that this molecule is DC-SIGN by peptide amino acid sequencing of the44kDa immunoprecipitated protein revealed it to be100% identical to a previously described HIV-1gp120-bindingC-type lectin(Curtis et al.,1992)isolated from a placen-identical in its amino acid sequence to the HIV-1enve-tal cDNA library.Here,we demonstrate that this HIV-1-lope glycoprotein gp120-binding C-type lectin pre-binding protein,which is highly expressed on DC pres-viously isolated from a placental cDNA library(Curtis et ent at mucosal sites,specifically captures HIV-1and al.,1992).To determine whether this molecule has a role promotes infection in trans of target cells that express in binding of HIV to DC,we used a flow cytometric CD4and appropriate chemokine receptors.Our findings adhesion assay(Geijtenbeek et al.,1999)to examine suggest that,during transmission of HIV-1,the virus the ability of HIV-1gp120-coated fluorescent beads to initially binds to mucosal DC through DC-SIGN,allowing bind to immature DC(Figure1B).The gp120-coated subsequent transport to secondary lymphoid organs beads bound efficiently to the DC,and the binding was and highly efficient infection of CD4ϩT cells by a novel completely blocked by the anti-DC-SIGN antibodies trans infection mechanism.AZN-D1and AZN-D2.In contrast,neutralizing anti-CD4antibodies had no effect on gp120binding to DC.This Results result indicates that,although the primary HIV-1recep-tor CD4is expressed on DC(Figure1C),HIV-1gp120 DC-SIGN Is a DC-Specific HIV-1-Binding Proteinpreferentially binds to DC-SIGN.Similarly,the mono-DC-SIGN was recently identified as a DC-specific ICAM-3cytic cell line THP-1,which lacks expression of both adhesion receptor that mediates DC-T cell interactionsCD4and CCR5,bound the gp120-coated beads afterDC-SIGN Is a Novel HIV-1trans Receptor589Figure2.DC-SIGN Mediates HIV-1Infection in a DC-T Cell Coculture(A)Antibodies against DC-SIGN inhibit HIV-1infection as measured in a DC-T cell coculture.DC(50ϫ103)were preincubated for20min at room temperature with blocking mAb against CD4(RPA-T4)or DC-SIGN(AZN-D1and AZN-D2)(20g/ml)or with a combination of CCR5-specific chemokines(CCR5trio:RANTES,MIP-1␣,and MIP1;500ng/ml).Preincubated immature DC were pulsed for2hr with HIV-1 (M-tropic HIV-1Ba-L strain),and unbound virus particles and mAb were washed away.Subsequently,DC were cocultured with activated PBMC (50ϫ103)for9days.Coculture supernatants were collected,and p24antigen levels were measured by ELISA.One representative experiment out of two is shown.(B)Inhibition of HIV-1infection in a DC-T cell coculture by blocking DC-SIGN,CD4,and CCR5.HIV-1replication in the DC-T cell coculture at day5of the experiment is described in Figure5A.The results of day5are representative for days6,7,and9of DC-T cell coculture.DC were also preincubated with mAb against DC-SIGN together with anti-CD4and CCR5-specific chemokines.p24values represent meanϮSD of triplicate cultures.One representative experiment out of two is shown.(C)DC-SIGN interactions with ICAM-3are not involved in the transmission of DC-bound-HIV-1to T cells.DC(50ϫ103)were pulsed for2hr with HIV-1(M-tropic HIV-1Ba-L strain),washed,and cocultured with activated PBMC(50ϫ103)for9days in the presence of the CCR5-specific chemokines(CCR5trio:RANTES,MIP-1␣,and MIP1;500ng/ml)or mAb against CD4(RPA-T4)and DC-SIGN(AZN-D1and AZN-D2)(20g/ ml).Antibodies were added post-HIV-1infection of DC,prior to the addition of PBMC.One representative experiment out of two is shown.it was transfected with a DC-SIGN expression vector presence of activated T cells(Figures2A and2B).To (Figure1C).HIV-1gp120binding to this cell line,THP-determine the contribution of each of these receptors DC-SIGN,was also blocked by anti-DC-SIGN antibod-in this assay system,we examined the effects of anti-ies,but not by anti-CD4(Figure1D).Binding of HIV-1bodies against CD4and DC-SIGN and of a combination gp120to DC-SIGN expressed on DC or THP-DC-SIGN of three CCR5-specific chemokines(RANTES,MIP-1␣, was also inhibited by the carbohydrate mannan or EGTA,and MIP-1).Preincubation of the immature DC with consistent with previous findings(Curtis et al.,1992)antibodies against DC-SIGN prior to infection resulted and with the observation that DC-SIGN is homologousin significant inhibition of HIV-1replication(Figure2A). to other members of the Ca2ϩ-binding mannose-type Neither anti-CD4nor the CCR5-specific chemokines in-lectins(Weis et al.,1998).Together,these results dem-hibited on their own,although a combination of these onstrate that DC-SIGN is a specific dendritic cell surface did block infection of DC(Figure2A),which is probably receptor for the HIV-1envelope glycoprotein.due to efficient inhibition of the T cell infection by(un)-bound anti-CD4/chemokines.Activated T cells chal-DC-SIGN Is Required for Efficient HIV-1Infectionlenged with the same viral load exhibited a weaker infec-in DC-T Cell Cocultures tion than those cultured with virus-pulsed DC(data not Because DC-SIGN is exclusively expressed on DC andshown).has a high affinity for HIV-1gp120,we reasoned that it Since DC-SIGN binds to ICAM-3on T cells,it is possi-might play an important role in HIV-1infection of DC orble that antibodies against DC-SIGN could interfere with of T cells that make contact with DC.Immature DC,the DC-T cell interaction and thereby prevent HIV-1 which express low levels of CD4as well as CCR5andtransmission.To examine this possibility,antibodies abundant DC-SIGN(Figure1C),were pulsed with the against DC-SIGN were added after exposure of DC to R5isolate HIV-1BA-L for2hr,washed,and cultured in theHIV-1but prior to the addition of activated T cells.InCell590this setting,only CCR5-specific chemokines and anti-CD4antibody strongly inhibited HIV-1infection of acti-vated T cells,while antibodies against DC-SIGN had noeffect(Figure2C).These results thus suggest that DC-SIGN has an important function in propagation of HIV-1in DC-T cell cocultures and that this function is relatedto the ability of DC-SIGN to bind to gp120and not toits interaction with ICAM-3.DC-SIGN Does Not Mediate HIV-1EntryTo investigate whether DC-SIGN acts as a receptor thatpermits HIV-1entry,similar to CD4plus CCR5,we stud-ied HIV-1entry into293T cells that expressed either DC-SIGN(293T-DC-SIGN)or CD4and CCR5(293T-CD4-CCR5).Cells were pulsed overnight with HIV BA-L andwashed the next day,and p24levels were determined.There was no detectable p24protein in the culture su-pernatants harvested from293-DC-SIGN cells severaldays after the HIV-1pulse,whereas the293T-CD4-CCR5cells were readily infected(Figure3A).To examine the possibility that DC-SIGN may work inconjunction with either CD4or CCR5to permit viralentry,we extended the studies by using HIV-1pseu-dotyped with the envelope glycoprotein of the R5isolateHIV-1ADA.We employed a replication-defective HIV-1ge-nome that encoded a luciferase reporter gene,whichallows a quantitative measure of the levels of single-round infection(Figure3B)(Deng et al.,1996).Tran-siently transfected293T cells expressing either CCR5(293T-CCR5),CD4(293T-CD4),or both(293T-CD4-CCR5),in the presence or absence of DC-SIGN,wereinfected with the reporter virus,and luciferase levelswere determined after2days.As observed with replicat-Figure3.DC-SIGN Expressed on Target Cells Does Not MediateHIV-1Entrying virus,HIV-1entry was not detected in293T cells(A)293T cells were transfected with DC-SIGN or CD4and CCR5 that expressed only DC-SIGN(Figure3B).No infectionand pulsed for2hr with HIV-1(CCR5-tropic HIV-1Ba-L strain).Subse-was observed if DC-SIGN was expressed with eitherquently,cells were cultured for9days.Supernatants were collected, CD4or CCR5,indicating that DC-SIGN does not formand p24antigen levels were measured by ELISA.One representative a complex with these molecules to permit viral entry.experiment of two is shown.In contrast,high luciferase activity was obtained after(B)293T cells and293T cells stably expressing either CD4,CCR5,infection of293T cells expressing both CD4and CCR5,or CD4and CCR5were transiently transfected with DC-SIGN andsubsequently infected with pseudotyped CCR5-tropic HIV-1ADA virus and expression of DC-SIGN did not contribute furtherin the presence of polybrene(20g/ml).Luciferase activity was to viral entry into these cells(Figure3B).Therefore,DC-evaluated after2days.One representative experiment out of three SIGN cannot substitute for CD4or CCR5in the processis shown.of HIV-1entry.DC-SIGN Captures HIV-1and Facilitates Infection viral entry(Figure4A).HIV-1capture was completelyof HIV-1Permissive Cells In transDC-SIGN dependent,as antibodies against DC-SIGNBecause DC-SIGN did not appear to mediate virus entry inhibited HIV-1infection(Figure4A),and DC-SIGN-neg-into target cells,we hypothesized that in a DC-T cellative parental THP-1cells were unable to capture andcoculture(Figure2)DC-SIGN might facilitate both cap-transmit HIV-1(Figures4A and4B).Similar to our previ-ture of HIV-1on DC,independent from CD4and CCR5,ous findings,the DC-SIGN-mediated infection of theand subsequent transmission of HIV-1to the CD4/target cells was not due to DC-SIGN binding to ICAM-3,CCR5-positive T cells.To test this,THP-DC-SIGNsince293T cells are ICAM-3negative.These findingstransfectants,which do not express CD4or CCR5(Fig-indicate that DC-SIGN expressed at the surface of heter-ure1C)and which cannot be infected by HIV-1(dataologous cells can capture HIV-1in a form that retains itsnot shown),were pulsed with single-round HIV-lucifer-capacity to subsequently infect HIV-1-permissive cells.ase virus pseudotyped with the HIV-1ADA envelope glyco-The ability of DC-SIGN to capture and transmit HIV-1protein.After washing to remove unbound virus,the was also observed with HIV-luciferase viruses pseu-cells were cocultured with CD4/CCR5-expressing293Tdotyped with envelope glycoproteins from an additionalcells,which are permissive for HIV-1infection,or acti-five R5isolates,including three primary isolates(Figurevated T lymphocytes.THP-DC-SIGN cells were able to4B),and from the X4isolate HXB2(data not shown).capture the pseudotyped virus and transmit it to the Analysis of luciferase activity in both adherent(293T-target cells that expressed the receptors required forCD4-CCR5)and nonadherent(THP-DC-SIGN)cell frac-DC-SIGN Is a Novel HIV-1trans Receptor591tions after2days of coculture demonstrated that pro-ductive HIV-1infection occured only in the HIV-1permis-sive293T-CD4-CCR5cells(data not shown).Similarly,by using a pseudotyped HIV-1vector with the greenfluorescent protein gene in place of Nef(HIV-eGFP),wedemonstrated that cells expressing CD4/CCR5and notthose expressing DC-SIGN were infected in cocultures.Thus,after coculture of virus-pulsed THP-DC-SIGN cellswith T cells,only the CD3ϩT cells expressed virus-encoded GFP(Figure4C).Sexual transmission of HIV-1is likely to require ameans for small amounts of virus to gain access to cellsthat are permissive for viral replication.This may beachieved because of the ability of virus to interact withDC,which can capture HIV-1and present it to the per-missive cells.To mimic in vivo conditions in which HIV-1levels are likely to be limiting,we challenged THP-1transfectants with low titers of pseudotyped HIV-1andsubsequently cocultured these cells with HIV-1permis-sive cells,without washing away unbound virus(Figure5A).As expected,neither293T-CD4-CCR5cells nor acti-vated T cells were efficiently infected with the low titersof pseudotyped HIV-1(Figure5A).Strikingly,when thesepermissive cells were challenged with an identicalamount of HIV-1in the presence of THP-DC-SIGN,butnot of the parental THP-1cells,efficient HIV-1infectionwas observed in trans(Figure5A).The enhancement ofHIV-1infection of primary T cells by DC-SIGN was alsoobserved with HIV-luciferase viruses pseudotyped withfive other R5envelopes,including three from primaryvirus isolates(Figure5B).These results indicate thatDC-SIGN not only sequesters HIV-1but also enhancesCD4-CCR5-mediated HIV-1entry by presentation in transto the HIV-1receptor complex.Antibodies against DC-SIGN completely inhibited infection(Figure5A),demon-strating that the efficient enhancement of HIV-1entryinto CD4/CCR5-positive cells is DC-SIGN dependent.DC Present in Mucosal Tissues at Sites of HIV-1Exposure Express DC-SIGN and Are CCR5NegativeDemonstration that cells that express DC-SIGN can cap-ture HIV-1and efficiently transmit the virus to other cellsin trans suggested that DC that express this C-typelectin have a key role in viral infection in vivo.To deter-mine whether such cells are indeed present in vivo,weperformed immunohistochemical analyses of mucosal Figure4.DC-SIGN Captures HIV-1that Retains Infectivity for CD4ϩT Cells tissues that are the sites of first exposure during sexual (A)DC-SIGN captures HIV-1and facilitates infection of HIV-1permis-transmission of HIV-1(Figure6A).DC-SIGN was ex-sive cells in trans.DC-SIGN transfectants(100ϫ103)were preincu-pressed on DC-like cells with large and very irregular bated for20min at room temperature with blocking mAb against morphology that were present in the mucosal tissues, DC-SIGN(AZN-D1and AZN-D2;20g/ml).The THP-DC-SIGN cells such as cervix,rectum,and uterus(Figures6Aa,6Ab, were infected with HIV-luciferase virus pseudotyped with R5strainand6Ac,respectively),in regions beneath the stratified HIV-1ADA Env.Alternatively activated T cells were infected with pseu-dotyped HIV-1ADA virus.After2hr at37ЊC,the infected cells wereextensively washed and added to either293T-CD4-CCR5cells oractivated primary T cells(100ϫ103).HIV-1infection was determinedafter2days by measuring the luciferase activity.One representative(C)Activated T cells are infected by HIV-1in the T cell/THP-DC-experiment out of three is shown.SIGN coculture.THP-DC-SIGN cells were incubated with HIV-eGFP(B)DC-SIGN is able to mediate capture of HIV-1viruses pseu-viruses pseudotyed with M-tropic HIV-1ADA and subsequently cocul-dotyped with M-tropic HIV-1envelopes from different primary iso-tured with activated T cells.The CD3-negative THP-DC-SIGN cellslates.DC-SIGN-mediated capture was performed as described in were not infected by HIV-1,whereas the CD3-positive T cells were(A)on293T-CD4-CCR5with HIV-luciferase viruses pseudotyped infected.T cells,gated by staining for CD3(tricolor),were positivewith the CCR5-specific HIV-1envelopes from JRFL and JRCSF and for eGFP,whereas CD3-negative THP-DC-SIGN that initially cap-from primary viruses92US715.6,92BR020.4,and93TH966.8.One tured HIV-eGFP did not express eGFP.One representative experi-representative experiment out of two is shown.ment out of two is shown.Cell592infectivity during the transport from the mucosal tissuesto the T cell zones in draining lymph nodes.To determineif virus bound to DC-SIGN retains infectivity for a pro-longed period of time,we first conducted a time-courseexperiment to determine the length of time that HIV-1gp120remains bound to DC-SIGN expressed on trans-fected THP-1cells.We observed that gp120-coatedbeads remained bound to DC-SIGN for more than60hr(Figure7A).We next investigated the length of time dur-ing which HIV-1-pulsed THP-DC-SIGN cells could retaininfectious virus.The DC-SIGN-expressing transfectantswere pulsed with pseudotyped HIV-1for4hr and thenwashed extensively.The pulsed cells were subsequentlyplaced in culture and were removed at defined intervalsand cocultured with activated T cells(Figure7B).Re-markably,after4days the HIV-1-pulsed cells were stillable to efficiently infect target cells.In contrast,virus inthe absence of DC-SIGN-positive cells lost its infectivityafter1day.These findings support the hypothesis thatlimiting numbers of HIV-1particles,captured by muco-sal DC that express DC-SIGN and CD4but not CCR5,retain infectivity during and after migration to regionallymphoid tissues.T cells,which express CD4and CCR5,would then be productively infected due to DC-SIGN-mediated enhanced trans infectivity of the small num-bers of HIV-1particles(Figure7C).DiscussionFigure5.DC-SIGN Enhances HIV-1Infection of T Cells by Acting We have identified a novel DC-specific adhesion recep-In trans tor,DC-SIGN,that is identical to the high-affinity HIV-1 At a low virus load,DC-SIGN in trans is crucial for the infection gp120-binding C-type lectin cloned from a human pla-of HIV-1permissive cells.THP-1transfectants(100ϫ103)were cental cDNA library(Geijtenbeek et al.,2000).We havepreincubated for20min at room temperature with blocking mAbdemonstrated that DC that express both DC-SIGN and against DC-SIGN(AZN-D1and AZN-D2;20g/ml).The cells wereCD4preferentially use DC-SIGN to capture HIV-1via its infected by low amounts of pseudotyped HIV-1ADA virus(A)or otherhigh affinity for HIV-1gp120.DC-SIGN not only effi-R5isolates of HIV-1(B),i.e.,at the threshold of detection in a singleround infection assay.After1hr at37ЊC,the cell/virus suspension ciently recruits HIV-1but also facilitates HIV-1infection was directly added to either293T-CD4-CCR5or activated T cells of CD4ϩT cells by a novel in trans mechanism.Our (100ϫ103).The infectivity was determined after2days by measuring findings thus indicate that HIV-1utilizes a novel receptorthe luciferase activity.One representative experiment out of two isstrategy that has not been previously described in other shown.viral systems,and suggest that the virus exploits multi-ple cell surface receptor systems to ensure that it can squamous epithelium in the lamina propria.Analyses ofestablish a productive infection in its host organism. serial sections stained for CD3,CD20,CD14,and CD68DC localized in the skin and mucosal tissues such as confirmed that DC-SIGN-expressing cells were distinctthe rectum,uterus,and cervix have been proposed to from T cells,B cells,monocytes,and macrophages(dataplay a role in initial HIV-1infection.DC constitute a not shown).Similarly,in the accompanying paper(Geij-heterogeneous population of cells that are present in tenbeek et al.,2000),staining of lymph nodes and skinminute numbers in various tissues just beneath the der-has shown DC-restricted expression of DC-SIGN.Wemis or mucosal layer and form a first-line defense have also compared expression of DC-SIGN,CD4,andagainst viruses and other pathogens.DC have pre-CCR5on DC in the mucosa of the uterus and rectumviously been shown to sequester HIV-1and efficiently and found in serial sections that the majority of DC-transmit the virus to CD4ϩT cells.We have demon-SIGN-positive DC in these tissues coexpressed CD4butstrated here that this property of DC can be ascribed lacked CCR5(Figure6B).This suggests that DC presentto the ability of HIV-1to bind specifically to these cells at mucosal sites,that have first contact with HIV-1duringthrough the interaction of gp120with DC-SIGN.DC thus sexual transmission,are not infected with HIV-1throughefficiently capture HIV-1through a specific interaction usage of CD4/CCR5.This observation is consistent withthat is independent from binding of virus to CD4and the recent demonstration that DC at sites of mucosalCCR5.DC-SIGN cannot mediate HIV-1entry but rather infection of nonhuman primates do not become infectedfunctions as a unique HIV-1trans receptor facilitating (Stahl-Hennig et al.,1999).HIV-1infection of CD4/CCR5-positive T cells(Figures4and5).At low virus titer,CD4/CCR5-expressing cells DC-SIGN-Bound HIV-1Retains Infectivityare not detectably infected without the help of DC-SIGN after Long-Term Culturein trans(Figure5A).Conditions in which the number of If HIV-1gains access to secondary lymphoid organs byway of binding to DC,then virus would have to retain HIV-1particles is limiting are likely to resemble those。